May 7 (Reuters) - Gilead Sciences GILD.O on Wednesday announced $11 billion in capital and operational investments in the U.S. to supplement an already planned spending of $21 billion in domestic manufacturing and R&D through 2030.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.